ArticleBMC gastroenterology2026
Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to estimate the frequency of H. pylori infection in patients with liver disorders, and identify the relationship between vitamin D receptor gene variants and susceptibility to H. pylori infections and HCC in Egyptian patients with liver diseases. MATERIALS AND
methodsThis study consists of 300 adult patients classified into three groups: 100 healthy controls, 100 patients with liver cirrhosis, and 100 patients with HCC. Every patient was assessed for the presence of H. pylori by rapid test and polymerase chain reaction (PCR). Estimation of FokI and BsmI VDR gene polymorphism was performed by restriction fragment length polymorphism-Polymerase chain reaction (RFLP-PCR).
resultsInfection with H. pylori was present in 46.7% of cases overall. Liver cirrhosis (LC) patients had a higher prevalence of H. pylori infection, followed by HCC patients (59% and 42%, respectively). Patients with LC and HCC were shown to be CagA positive, with the target CagA oncogene gene having an expected product size of 37.3% and 35.7%, respectively. LC and HCC patients showed a significant difference between the H. pylori-positive and -negative groups. Concerning the BsmI polymorphism, HCC patients with H. pylori-CagA positive had a higher GC genotype than those with H. pylori-CagA negative, and LC and HCC patients with H. pylori-CagA positive had a higher TT genotype than those with H. pylori-CagA negative.
conclusionFokI and BsmI VDR polymorphisms may be linked to H. pylori infection and CagA strain susceptibility in patients with LC and HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.